In addition, conbercept had no limited influence on the aqueous levels of IFN-γ and MCP-1, which is consistent with a previous study investigating the impact of conbercept on vitreous inflammatory cytokines in patients with diabetic macular edema [24]. This evidence concerns the gene CCL2 and diabetic macular edema.